Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ OMA1 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5106421
Description
Antibody detects endogenous levels of total OMA1.
OMA1 (Overlapping with the m-AAA protease 1 homolog) is also named as MPRP1(Metalloprotease-related protein 1) and belongs to the peptidase M48 family. It is a zinc metalloprotease that spans the inner mitochondrial membrane with a number of predicted membrane spanning domains and the 60 kDa form of OMA1 rapidly accumulated concomitantly with the cleavage of all OPA1 variants, and the 40 kDa form of OMA1 may be the inactive form, with the 60 kDa form being the active enzyme.
Specifications
OMA1 | |
Polyclonal | |
Unconjugated | |
OMA1 | |
2010001O09Rik; DAB1; metalloendopeptidase OMA1, mitochondrial; metalloprotease related protein 1; metalloprotease-related protein 1; MPRP1; MPRP-1; Oma1; OMA1 homolog, zinc metallopeptidase; OMA1 homolog, zinc metallopeptidase (S. cerevisiae); OMA1 zinc metallopeptidase; OMA1 zinc metallopeptidase homolog; overlapping activity with M-AAA protease; overlapping with the m-AAA protease 1 homolog; peptidase; RGD1304821; YKR087C; zinc metallopeptidase homolog; zinc metallopeptidase OMA1; ZMPOMA1 | |
Rabbit | |
Affinity chromatography | |
RUO | |
115209, 298282, 67013 | |
-20°C | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
1 mg/mL | |
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
D3ZS74, Q96E52, Q9D8H7 | |
OMA1 | |
A synthesized peptide derived from human OMA1(Accession Q96E52), corresponding to amino acid residues K405-Q455. | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction